The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma

Radiotherapy and Oncology

Volumn 72, Issue 2, 2004, Pages 159-168

  Hoskin, Peter J ^a   Sibtain, Amen ^a   Daley, Frances M ^b   Saunders, Michele I ^a   Wilson, George D ^b  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Hypoxia; Pimonidazole; Proliferation; Vascularity

Indexed keywords

BIOCHEMICAL MARKER; CD31 ANTIGEN; CD34 ANTIGEN; CYCLIN A; KI 67 ANTIGEN; PIMONIDAZOLE;

AGED; ANTIGEN DETECTION; ARTICLE; BLADDER CARCINOMA; CANCER RADIOTHERAPY; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOXIC CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RADIATION RESPONSE; STAINING; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TUMOR VASCULARIZATION;

ANTIGENS, CD31; ANTIGENS, CD34; CARCINOMA, TRANSITIONAL CELL; CELL HYPOXIA; CELL PROLIFERATION; CYCLIN A; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NITROIMIDAZOLES; RADIATION-SENSITIZING AGENTS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 3543137677     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.03.017     Document Type: Article

References (41)

1. Airley R.E., Loncaster J., Raleigh J.A., et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer. 104:2003;85-91
2. Amellem O., Pettersen E.O. Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif. 24:1991;127-141
3. Arteel G.E., Thurman R.G., Raleigh J.A. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem. 253:1998;743-750
4. Beasley N.J., Wykoff C.C., Watson P.H., et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 61:2001;5262-5267
5. Bedford J.S., Mitchell J.B. The effect of hypoxia on the growth and radiation response of mammalian cells in culture. Br J Radiol. 47:1974;687-696
6. Begg A.C., Janssen H., Sprong D., et al. Hypoxia and perfusion measurements in human tumors - initial experience with pimonidazole and IUdR. Acta Oncol. 40:2001;924-928
7. Bussink J., Kaanders J.H., Rijken P.F., Martindale C.A., van der Kogel A.J. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br J Cancer. 77:1998;57-64
8. Chaudhary R., Bromley M., Clarke N.W., et al. Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res. 19:1999;3479-3484
9. Evans S.M., Hahn S.M., Magarelli D.P., Koch C.J. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. Am J Clin Oncol. 24:2001;467-472
10. Giatromanolaki A., Koukourakis M.I., Sivridis E., et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 61:2001;7992-7998
11. Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 93:2001;266-276
12. Hoskin P.J., Sibtain A., Daley F.M., Wilson G.D. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vacularity and proliferation as predictors of outcome of ARCON. Br J Cancer. 89:2003;1290-1297
13. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 62:2002;7066-7074
14. Kennedy A.S., Raleigh J.A., Perez G.M., et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys. 37:1997;897-905
15. Koch C.J., Kruuv J., Frey H.E., Snyder R.A. Plateau phase in growth induced by hypoxia. Int J Radiat Biol Relat Stud Phys Chem Med. 23:1973;67-74
16. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res. 7:2001;3399-3403
17. Lara P.C., Rey A., Santana C., et al. The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy. Radiother Oncol. 49:1998;163-167
18. Nordsmark M., Hoyer M., Keller J., Nielsen O.S., Jensen O.M., Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 35:1996;701-708
19. Nordsmark M., Loncaster J., Chou S.C., et al. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int J Radiat Oncol Biol Phys. 49:2001;581-586
20. Olive P.L., Durand R.E., Raleigh J.A., Luo C., Aquino-Parsons C. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br J Cancer. 83:2000;1525-1531
21. Oosterhuis J.W., Schapers R.F., Janssen-Heijnen M.L., Smeets A.W., Pauwels R.P. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors. Cancer. 88:2000;2598-2605
22. Overgaard J., Horsman M.R. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 6:1996;10-21
23. Petrovich Z., Jozsef G., Brady L.W. Radiotherapy for carcinoma of the bladder: a review. Am J Clin Oncol. 24:2001;1-9
24. Pettersen E.O., Lindmo T. Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S. Br J Cancer. 43:1981;355-366
25. Raleigh J.A., Zeman E.M., Calkins D.P., McEntee M.C., Thrall D.E. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncol. 34:1995;345-349
26. Raleigh J.A., Calkins-Adams D.P., Rinker L.H., et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res. 58:1998;3765-3768
27. Raleigh J.A., Chou S.C., Arteel G.E., Horsman M.R. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res. 151:1999;980-989
28. Raleigh J.A., Chou S.C., Calkins-Adams D.P., Ballenger C.A., Novotny D.B., Varia M.A. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas. Clin Cancer Res. 6:2000;855-862
29. Sagol O., Yorukoglu K., Sis B., et al. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder? Urology. 57:2001;895-899
30. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845
31. Spiro I.J., Rice G.C., Durand R.E., Stickler R., Ling C.C. Cell killing, radiosensitization and cell cycle redistribution induced by chronic hypoxia. Int J Radiat Oncol Biol Phys. 10:1984;1275-1280
32. Toi M., Hoshina S., Takayanagi T., Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res. 85:1994;1045-1049
33. Toi M., Inada K., Hoshina S., Suzuki H., Kondo S., Tominaga T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res. 1:1995;961-964
34. Toi M., Inada K., Suzuki H., Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat. 36:1995;193-204
35. Takano S., Yoshii Y., Kondo S., et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56:1996;2185-2190
36. Tsang R.W., Fyles A.W., Milosevic M., et al. Interrelationship of proliferation and hypoxia in carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 46:2000;95-99
37. Tomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. IX:1955;539-549
38. Webster L., Hodgkiss R.J., Wilson G.D. Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo. Br J Cancer. 77:1998;227-234
39. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8
40. Wijffels K.I., Kaanders J.H., Rijken P.F., et al. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br J Cancer. 83:2000;674-683
41. Wykoff C.C., Beasley N.J.P., Watson P.H., et al. Hypoxia-inducible regulation of tumor-associated carbonic anhydrases. Cancer Res. 60:2000;7075-7083